• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶 L 在加工和储存过程中导致中国仓鼠卵巢细胞表达蛋白的蛋白水解切割:鉴定、表征和缓解。

Cathepsin L Causes Proteolytic Cleavage of Chinese-Hamster-Ovary Cell Expressed Proteins During Processing and Storage: Identification, Characterization, and Mitigation.

机构信息

Purification Process Sciences, Medimmune LLC, Gaithersburg, MD 20878.

Analytical Sciences, Medimmune LLC, Gaithersburg, MD 20878.

出版信息

Biotechnol Prog. 2019 Jan;35(1):e2732. doi: 10.1002/btpr.2732. Epub 2018 Nov 4.

DOI:10.1002/btpr.2732
PMID:30320962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6587562/
Abstract

A stochastic approach of copurification of the protease Cathepsin L that results in product fragmentation during purification processing and storage is presented. Cathepsin L was identified using mass spectroscopy, characterization of proteolytic activity, and comparison with fragmentation patterns observed using recombinant Cathepsin L. Cathepsin L existed in Chinese hamster ovary cell culture fluids obtained from cell lines expressing different products and cleaved a variety of recombinant proteins including monoclonal antibodies, antibody fragments, bispecific antibodies, and fusion proteins. Therefore, characterization its chromatographic behavior is essential to ensure robust manufacturing and sufficient shelf life. The chromatographic behaviors of Cathepsin L using a variety of techniques including affinity, cation exchange, anion exchange, and mixed mode chromatography were systematically evaluated. Our data demonstrates that copurification of Cathepsin L on nonaffinity modalities is principally because of similar retention on the stationary phase and not through interactions with product. Lastly, Cathespin L exhibits a broad elution profile in cation exchange chromatography (CEX) likely because of its different forms. Affinity purification is free of fragmentation issue, making affinity capture the best mitigation of Cathepsin L. When affinity purification is not feasible, a high pH wash on CEX can effectively remove Cathepsin L but resulted in significant product loss, while anion exchange chromatography operated in flow-through mode does not efficiently remove Cathepsin L. Mixed mode chromatography, using Capto™ adhere in this example, provides robust clearance over wide process parameter range (pH 7.7 ± 0.3 and 100 ± 50 mM NaCl), making it an ideal technique to clear Cathepsin L. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 35: e2732, 2019.

摘要

本文提出了一种蛋白酶 Cathepsin L 的共纯化的随机方法,该方法在纯化过程和储存过程中导致产物碎片化。Cathepsin L 通过质谱分析、蛋白水解活性的表征以及与使用重组 Cathepsin L 观察到的碎片化模式进行比较来鉴定。Cathepsin L 存在于表达不同产物的中国仓鼠卵巢细胞培养物中,并切割多种重组蛋白,包括单克隆抗体、抗体片段、双特异性抗体和融合蛋白。因此,其色谱行为的表征对于确保稳健的制造和足够的货架期至关重要。使用各种技术,包括亲和、阳离子交换、阴离子交换和混合模式色谱法,系统地评估了 Cathepsin L 的色谱行为。我们的数据表明,Cathepsin L 在非亲和模式下的共纯化主要是由于在固定相上的相似保留,而不是通过与产物的相互作用。最后,Cathespin L 在阳离子交换色谱(CEX)中表现出广泛的洗脱谱,可能是因为它的不同形式。亲和纯化没有碎片化问题,因此亲和捕获是减轻 Cathepsin L 的最佳方法。当亲和纯化不可行时,CEX 上的高 pH 洗涤可以有效地去除 Cathepsin L,但会导致产物大量损失,而阴离子交换色谱以流穿模式操作则不能有效地去除 Cathepsin L。混合模式色谱法,在本示例中使用 Capto™ adhere,在广泛的工艺参数范围内(pH 7.7±0.3 和 100±50 mM NaCl)提供强大的清除效果,使其成为清除 Cathepsin L 的理想技术。©2018 美国化学工程师协会生物技术进展,35:e2732,2019。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/2037d9d601c2/BTPR-35-na-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/afdbe9144ed7/BTPR-35-na-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/0c417def100c/BTPR-35-na-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/b1538c953834/BTPR-35-na-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/89316db41394/BTPR-35-na-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/87499f187d72/BTPR-35-na-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/1964df89b007/BTPR-35-na-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/2037d9d601c2/BTPR-35-na-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/afdbe9144ed7/BTPR-35-na-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/0c417def100c/BTPR-35-na-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/b1538c953834/BTPR-35-na-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/89316db41394/BTPR-35-na-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/87499f187d72/BTPR-35-na-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/1964df89b007/BTPR-35-na-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3afc/6587562/2037d9d601c2/BTPR-35-na-g007.jpg

相似文献

1
Cathepsin L Causes Proteolytic Cleavage of Chinese-Hamster-Ovary Cell Expressed Proteins During Processing and Storage: Identification, Characterization, and Mitigation.组织蛋白酶 L 在加工和储存过程中导致中国仓鼠卵巢细胞表达蛋白的蛋白水解切割:鉴定、表征和缓解。
Biotechnol Prog. 2019 Jan;35(1):e2732. doi: 10.1002/btpr.2732. Epub 2018 Nov 4.
2
Characterization of a cathepsin D protease from CHO cell-free medium and mitigation of its impact on the stability of a recombinant therapeutic protein.从CHO无细胞培养基中鉴定组织蛋白酶D蛋白酶并减轻其对重组治疗性蛋白稳定性的影响。
Biotechnol Prog. 2018 Jan;34(1):120-129. doi: 10.1002/btpr.2530. Epub 2017 Aug 9.
3
Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.CHO宿主细胞蛋白酶组织蛋白酶D的痕量水平导致了一种单克隆抗体产品中颗粒的形成。
Biotechnol Prog. 2015 Sep-Oct;31(5):1360-9. doi: 10.1002/btpr.2150. Epub 2015 Aug 25.
4
Cathepsin D: Removal strategy on protein A chromatography, near real time monitoring and characterisation during monoclonal antibody production.组织蛋白酶 D:在单克隆抗体生产过程中,在蛋白 A 层析上的去除策略、近实时监测和特性分析。
J Biotechnol. 2019 Nov 10;305:51-60. doi: 10.1016/j.jbiotec.2019.08.013. Epub 2019 Aug 20.
5
Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.过载阳离子交换层析法在单克隆抗体纯化中的应用探索。
J Chromatogr A. 2011 Sep 28;1218(39):6943-52. doi: 10.1016/j.chroma.2011.08.008. Epub 2011 Aug 12.
6
Effects of lysosomal biotherapeutic recombinant protein expression on cell stress and protease and general host cell protein release in Chinese hamster ovary cells.溶酶体生物治疗重组蛋白表达对中国仓鼠卵巢细胞中细胞应激、蛋白酶及宿主细胞总蛋白释放的影响
Biotechnol Prog. 2017 May;33(3):666-676. doi: 10.1002/btpr.2455. Epub 2017 Mar 29.
7
Targeted Capture of Chinese Hamster Ovary Host Cell Proteins: Peptide Ligand Discovery.靶向捕获中国仓鼠卵巢宿主细胞蛋白:肽配体发现。
Int J Mol Sci. 2019 Apr 8;20(7):1729. doi: 10.3390/ijms20071729.
8
Antibody purification from CHO cell supernatant using new multimodal membranes.使用新型多模式膜从CHO细胞上清液中纯化抗体。
Biotechnol Prog. 2017 May;33(3):658-665. doi: 10.1002/btpr.2454. Epub 2017 Mar 20.
9
Cation exchange chromatography performed in overloaded mode is effective in removing viruses during the manufacturing of monoclonal antibodies.在超负荷模式下进行的阳离子交换层析在单克隆抗体生产过程中有效去除病毒。
Biotechnol Prog. 2019 Sep;35(5):e2858. doi: 10.1002/btpr.2858. Epub 2019 Jun 14.
10
Effects of pH, conductivity, host cell protein, and DNA size distribution on DNA clearance in anion exchange chromatography media.pH、电导率、宿主细胞蛋白及DNA大小分布对阴离子交换色谱介质中DNA清除率的影响。
Biotechnol Prog. 2018 Jan;34(1):141-149. doi: 10.1002/btpr.2556. Epub 2017 Sep 30.

引用本文的文献

1
Model acetylcholinesterase-Fc fusion glycoprotein biotechnology system for the manufacture of an organophosphorus toxicant bioscavenging countermeasure.用于制造有机磷毒物生物清除对策的模型乙酰胆碱酯酶-Fc融合糖蛋白生物技术系统。
Bioeng Transl Med. 2024 Apr 25;9(5):e10666. doi: 10.1002/btm2.10666. eCollection 2024 Sep.
2
Detection of host cell microprotein impurities in antibody drug products.抗体药物制品中宿主细胞微小蛋白杂质的检测。
Nat Commun. 2024 Oct 4;15(1):8605. doi: 10.1038/s41467-024-51870-0.
3
Rapid identification of antibody impurities in size-based electrophoresis via CZE-MS generated spectral library.

本文引用的文献

1
Effects of lysosomal biotherapeutic recombinant protein expression on cell stress and protease and general host cell protein release in Chinese hamster ovary cells.溶酶体生物治疗重组蛋白表达对中国仓鼠卵巢细胞中细胞应激、蛋白酶及宿主细胞总蛋白释放的影响
Biotechnol Prog. 2017 May;33(3):666-676. doi: 10.1002/btpr.2455. Epub 2017 Mar 29.
2
Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.评估基于抗体的生物治疗药物中宿主细胞蛋白杂质引起的免疫原性风险。
AAPS J. 2016 Nov;18(6):1439-1452. doi: 10.1208/s12248-016-9948-4. Epub 2016 Jul 22.
3
Residual Host Cell Protein Promotes Polysorbate 20 Degradation in a Sulfatase Drug Product Leading to Free Fatty Acid Particles.
基于 CZE-MS 生成的光谱库的胶束电动毛细管电泳快速鉴定抗体杂质。
Sci Rep. 2024 Aug 30;14(1):20239. doi: 10.1038/s41598-024-70914-5.
4
Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells.CHO 细胞中重组治疗蛋白的降解及克服策略。
Appl Microbiol Biotechnol. 2024 Jan 29;108(1):182. doi: 10.1007/s00253-024-13008-6.
5
Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305.贝伐单抗生物类似药IBI305批准后生产细胞系变更的可比性策略及论证
Antib Ther. 2023 Aug 4;6(3):194-210. doi: 10.1093/abt/tbad017. eCollection 2023 Jul.
6
Effect of Host Cell Protein on Chinese Hamster Ovary Recombinant Protein Production and its Removal Strategies: A Mini Review.宿主细胞蛋白对中国仓鼠卵巢重组蛋白生产的影响及其去除策略:小型综述。
Curr Pharm Biotechnol. 2024;25(6):665-675. doi: 10.2174/1389201024666230818112633.
7
A review on potential of natural products in the management of COVID-19.天然产物在新冠病毒疾病管理中的潜力综述。
RSC Adv. 2021 May 12;11(27):16711-16735. doi: 10.1039/d1ra00644d. eCollection 2021 Apr 30.
8
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies.基于蛋白质的疫苗生产平台:从经典到下一代策略。
Biomolecules. 2021 Jul 21;11(8):1072. doi: 10.3390/biom11081072.
9
Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development.商业化治疗性蛋白药物的宿主细胞蛋白谱分析作为基于单克隆抗体的治疗性蛋白开发的基准
MAbs. 2021 Jan-Dec;13(1):1955811. doi: 10.1080/19420862.2021.1955811.
10
The lysosomal endopeptidases Cathepsin D and L are selective and effective proteases for the middle-down characterization of antibodies.溶酶体内切酶 Cathepsin D 和 L 是用于抗体中、下部分鉴定的选择性和有效蛋白酶。
FEBS J. 2021 Sep;288(18):5389-5405. doi: 10.1111/febs.15813. Epub 2021 Mar 27.
残留宿主细胞蛋白促进硫酸酯酶药物产品中聚山梨酯20的降解,导致游离脂肪酸颗粒的产生。
J Pharm Sci. 2016 May;105(5):1657-1666. doi: 10.1016/j.xphs.2016.02.029. Epub 2016 Mar 28.
4
An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis.一种活性32 kDa组织蛋白酶L直接从HT 1080纤维肉瘤细胞分泌,而非通过溶酶体胞吐作用分泌。
PLoS One. 2015 Dec 16;10(12):e0145067. doi: 10.1371/journal.pone.0145067. eCollection 2015.
5
Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.用于单克隆抗体纯化的色谱精制步骤中的宿主细胞蛋白杂质。
Biotechnol Bioeng. 2016 Jun;113(6):1260-72. doi: 10.1002/bit.25882. Epub 2015 Dec 14.
6
Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).使用二维数据独立液相色谱-质谱联用(E)进行宿主细胞蛋白定量分析。
Anal Chem. 2015 Sep 15;87(18):9186-93. doi: 10.1021/acs.analchem.5b01377. Epub 2015 Aug 27.
7
Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product.CHO宿主细胞蛋白酶组织蛋白酶D的痕量水平导致了一种单克隆抗体产品中颗粒的形成。
Biotechnol Prog. 2015 Sep-Oct;31(5):1360-9. doi: 10.1002/btpr.2150. Epub 2015 Aug 25.
8
The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.在工艺开发和生产过程中宿主细胞蛋白(HCP)鉴定的未来发展与基于风险的控制管理相关联。
Biotechnol Bioeng. 2015 Sep;112(9):1727-37. doi: 10.1002/bit.25628. Epub 2015 Jul 14.
9
Development of robust antibody purification by optimizing protein-A chromatography in combination with precipitation methodologies.通过优化蛋白A色谱法并结合沉淀方法来开发稳健的抗体纯化方法。
Biotechnol Bioeng. 2015 Nov;112(11):2292-304. doi: 10.1002/bit.25639. Epub 2015 Jul 31.
10
Purification process of recombinant monoclonal antibodies with mixed mode chromatography.采用混合模式色谱法纯化重组单克隆抗体的工艺
J Chromatogr A. 2015 May 8;1393:57-64. doi: 10.1016/j.chroma.2015.03.018. Epub 2015 Mar 14.